Virology Testing Market -
Regional Insights
On the basis of Geography, Virology
Testing Market is segmented into North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa. North America is projected to dominate the
virology testing market over the forecast period. According to the Centers for
Disease Control and Prevention (CDC), around 5,251 deaths were reported due to
influenza infection in 2015.
According to the National
Ambulatory Medical Care Survey: 2015 data findings, around 16.8 million people
visit to physician for treatment of infectious and parasitic diseases in U.S.
Moreover, according to a study from the Society for Risk Analysis, 2016, GDP
loss of a viral pandemic outbreak in the U.S. was recorded between US$ 34.4
billion and US$ 45.3 billion in 2015.
Furthermore, robust healthcare
infrastructure and highest healthcare spending in world makes the U.S. most
lucrative market. However, Asia Pacific is expected to witness high CAGR due to
outbreak of viral influenza and largest patient pool infected with HIV.
Virology testing consist of
diagnostic methods that help in early detection of the disease such as
hepatitis, influenza, HIV, sexually transmitted disease, RCV, and other viral
associated disease. Virology testing examines for detection of viral antigens,
nucleic acids, and antibodies in the given sample in order to confirm the
presence of particular viral infection. There are more than 100 viral diseases
identified.
In order to confirm viral
infections, virology testing inculcates various methods. Culture medium based
method in which virus is confirmed by colony formation over culture has been
traditionally used since long time. Although this method is widely acceptable
and easy to perform, it is often time consuming, as it takes few days to weeks
to confirm presence of particular virus. It is a serious limitation especially
in viral pandemics where loss of time could result in more widespread infection
and delay in management of the viral infection.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2037
New advanced molecular based
virology testing methods has been evolved in recent past such as immunoassay,
nucleic acid based amplification testing methods (PCR based methods), mass
spectrometry based detection methods and next generation genome sequencing
methods, which are accurate, quick, and provides result for diversified viral
infections.
Virology Testing Market- Market
Dynamics
Virology testing market is
projected to witness significant growth during forecast period with rising
prevalence of virus originated diseases such as flu, hepatitis, AIDS, and STDs,
Ebola, Influenza based viral infections, severe acute respiratory syndrome from
coronavirus, hemorrhagic fever etc. across world. Early and fast diagnosis of
virus infection is very essential to start treatment course.
According to the World Health
Organization (WHO), January 2018 factsheet, all types of influenza in
combination causes annual epidemics about 3 to 5 million cases with severe
stage of illness, which results in the
290 000 to 650 000 deaths worldwide annually. Although rapid diagnostic
tests are majorly used, PCR based techniques are being adopted for detection of
influenza.
According Report on Global
Sexually Transmitted Infection Surveillance published in 2015 by WHO, in 2012,
an estimated 357 million new infections, which is equivalent to roughly 1
million patients per day were reported for the four curable sexually
transmitted disease such as chlamydia, gonorrhea, syphilis, and trichomoniasis.
Furthermore, advances in
anti-viral therapy in terms of detection techniques, medication, and vaccines
are expected to drive the virology testing market growth. Worldwide efforts are
going on to find novel vaccines and novel medication for treating viral
resistant diseases. For instance, Pritelivir is investigational drug for herpes
simplex virus (HSV) by AiCuris has proven to be very effective as compared to
the current standard antiviral treatments for genital herpes in Phase II
trials. Extensive research has been conducted worldwide for treatment of high
epidemic viral disease such as Ebola, Dengue, and Malaria.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/virology-testing-market-2037
New technologies for detecting
and curing viral disease could help in market expansion. For instance, the
nanoscale viral trap molecule technology, which is under research at present
can be applicable in diagnosing a viral disease. An innovative tunable device
selectively traps viruses detecting them with 100 times better sensitivity than
the current available techniques. Double-stranded RNA Activated Caspase
Oligomerizer (DRACO) is another nanoparticle based drug in research to treat
viral disease.
Virology Testing Market -
Competitive Landscape
Some of the key players operating
in the virology testing market include F. Hoffmann-La Roche AG., Bio-Rad Laboratories Inc. , Hologic Inc.,
Abbot Healthcare, Fujirebio Diagnostics Inc., Thermo Fisher Scientific Inc., Cepheid,
bioMerieux SA, Qiagen, Diasorin, Scienion AG, Siemens AG Grifols, Eiken Chemical Co Ltd., Sequenom, and
Diamedix Inc.
Key Development
In 2018, Bruker Corporation
acquired Hain Lifescience GmbH, a molecular diagnostics company. This
acquisiotn will expand the Bruker Corporation’s molecular diagnostic product
portfolio.
In 2018, QIAGEN N.V. and NeuMoDx
Molecular, Inc. entered into strategic partnership to commercialize two new
fully integrated systems for automation of PCR (polymerase chain reaction)
testing. These next-generation systems are specifically designed to help
clinical molecular diagnostic laboratories process.
In 2017, Quidel Corporation
entered into definitive agreement to acquire Triage MeterPro cardiovascular
(CV) and toxicology assets and the B-type Naturietic Peptide (BNP) assay
business from Alere Inc.
In 2015, Eurofins Scientific
acquired Diatherix Laboratories, Inc. which offers clinical laboratories
services on a multiplexing platform for the detection of infectious diseases.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2037
About
Coherent Market Insights:
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment